Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy
Xu Chen(Capital Medical University), Xiangliang Yang(Medical Protective), Zifu Li(Medical Protective), Shiyou Li(Temple College), Xing Wang(Nanjing Maternity and Child Health Care Hospital), Huimin Wang(Huazhong University of Science and Technology), Zheng Li(Huazhong University of Science and Technology), Jitang Chen(Huazhong University of Science and Technology), Jiayuan Li(Second Affiliated Hospital of Zhejiang University), Qingyuan Deng(Shihezi University), Yuxuan Xiong(Huazhong University of Science and Technology), Zhijie Zhang(Ningbo University)
Cited by 62
Related Papers
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
|Nature Communications|2019|803
Chemical Composition and Product Quality Control of Turmeric (Curcuma longa L.)
|Pharmaceutical Crops|2011|440
Precise nanomedicine for intelligent therapy of cancer
|Science China Chemistry|2018|413
Rational Design of Conjugated Small Molecules for Superior Photothermal Theranostics in the NIR‐II Biowindow
|Advanced Materials|2020|361
Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts
|Nature Communications|2022|247